There is no logic to waiting for earnings at all. You should have never followed and pumped cytocore and other non-earning stocks with that attitude. If you were talking logic and stating waiting for something that looks verifiably solid, I could see the sentiment change. Actual earnings is possibly a buy at pre-reverse price of $2.00. What has the company done for such a dramatic change in view? IR maybe not interested in your ideas. If you think the company is more risky than you did several months ago, then the mistake was a lack of caution on your part then. I think the press releases were a pumping disgrace prior to Taub but the fact the company is in tests now is important. sam